Literature DB >> 3711111

Characterization of Ca2+-stimulated secretion in permeable GH3 pituitary cells.

S A Ronning, T F Martin.   

Abstract

In this report, the secretory response to Ca2+ in GH3 rat pituitary cells permeabilized by electric field discharge has been compared in both magnitude and Ca2+ sensitivity to prolactin (PRL) release from intact GH3 cells. The half-maximally effective [Ca2+] for stimulating PRL release in permeable cells was approximately 0.5 microM, and maximal stimulation was obtained at 3-10 microM Ca2+. The magnitude of Ca2+ stimulation in permeable cells was in the same range as that obtained from an equal number of intact cells stimulated by depolarizing K+. Moreover, the Ca2+ sensitivity of PRL release in intact GH3 cells (measured by Quin 2 fluorescence) closely resembled the Ca2+ sensitivity determined in permeable cells. Release of a sulfated proteoglycan whose release is stimulated by secretagogues in intact cells was stimulated by Ca2+ in permeable cells with the same Ca2+ sensitivity as for PRL release. Maximal Ca2+ stimulation of PRL release in permeable cells required the addition of MgATP. Other energy sources (ADP, GTP, and inorganic phosphate) also supported Ca2+-stimulated secretion but were less effective. The above results indicated that PRL release from permeable cells resembles the physiological process in intact cells. The permeable cell system should prove useful in investigating the mechanism mediating the effect of Ca2+ on secretion, although our studies with pharmacological agents have so far proved inconclusive. Among calmodulin antagonists tested, only trifluoroperazine inhibited Ca2+-stimulated secretion, whereas pimozide and calmidazolium did not.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711111

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Thyroliberin-induced changes in the fluorescence of a membrane probe in individual bovine anterior pituitary cells.

Authors:  S L Shorte; S J Stafford; M Bamford; V J Collett; J G Schofield
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

2.  Adenosine 3',5'-cyclic monophosphate-mediated enhancement of calcium-evoked prolactin release from electrically permeabilised 7315c tumour cells.

Authors:  S Guild; E A Frey; S L Pocotte; J W Kebabian
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

3.  Micromolar free calcium exposes ouabain-binding sites in digitonin-permeabilized Xenopus laevis oocytes.

Authors:  G Schmalzing; S Kröner
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

4.  Mechanisms of luteinizing-hormone exocytosis in Staphylococcus aureus-alpha-toxin-permeabilized sheep gonadotropes.

Authors:  P A van der Merwe; R P Millar; I K Wakefield; J S Davidson
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

5.  Exocytosis in chromaffin cells: evidence for a MgATP-independent step that requires a pertussis toxin-sensitive GTP-binding protein.

Authors:  N Vitale; D Thiersé; D Aunis; M F Bader
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

6.  Hyperresponse in calcium-induced insulin release from electrically permeabilized pancreatic islets of diabetics GK rats and its defective augmentation by glucose.

Authors:  Y Okamoto; H Ishida; Y Tsuura; K Yasuda; S Kato; H Matsubara; M Nishimura; N Mizuno; H Ikeda; Y Seino
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

7.  Physiological characterization of two functional states in subpopulations of prolactin cells from lactating rats.

Authors:  P M Lledo; N Guerineau; P Mollard; J D Vincent; J M Israel
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

8.  Differential regulation of von Willebrand factor exocytosis and prostacyclin synthesis in electropermeabilized endothelial cell monolayers.

Authors:  J A Frearson; P Harrison; M C Scrutton; J D Pearson
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.